Jpmorgan Chase & CO Geron Corp Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Geron Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 519,674 shares of GERN stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

519,674

Previous 866,690 40.04%

Holding current value

$1.81 Million

Previous $3.67 Million 35.79%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$4.17 - $4.99 $1.45 Million - $1.73 Million	-347,016 Reduced 40.04%	519,674 $2.36 Million
Q2 2024 Aug 12, 2024	SELL	$3.1 - $5.09 $3.51 Million - $5.77 Million	-1,133,028 Reduced 56.66%	866,690 $3.67 Million
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $457,002 - $898,335	261,144 Added 15.02%	1,999,718 $6.6 Million
Q4 2023 Feb 12, 2024	BUY	$1.74 - $2.31 $190,335 - $252,686	109,388 Added 6.71%	1,738,574 $3.67 Million
Q3 2023 Nov 14, 2023	SELL	$2.11 - $3.28 $102,835 - $159,857	-48,737 Reduced 2.9%	1,629,186 $3.45 Million
Q2 2023 Aug 11, 2023	BUY	$1.97 - $3.69 $2.65 Million - $4.97 Million	1,347,019 Added 407.07%	1,677,923 $5.39 Million
Q1 2023 May 18, 2023	BUY	$2.14 - $3.4 $701,688 - $1.11 Million	327,892 Added 10886.19%	330,904 $718,000
Q1 2023 May 11, 2023	SELL	$2.14 - $3.4 $451,533 - $717,389	-210,997 Reduced 98.59%	3,012 $6,000
Q4 2022 Feb 13, 2023	SELL	$2.03 - $2.42 $21,810 - $26,000	-10,744 Reduced 4.78%	214,009 $518,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $22,007 - $38,743	13,178 Added 6.23%	224,753 $526,000
Q2 2022 Aug 11, 2022	BUY	$1.19 - $1.65 $23,026 - $31,927	19,350 Added 10.07%	211,575 $328,000
Q1 2022 May 11, 2022	BUY	$0.99 - $1.6 $44,997 - $72,723	45,452 Added 30.97%	192,225 $261,000
Q4 2021 Feb 10, 2022	BUY	$1.22 - $1.72 $10,987 - $15,490	9,006 Added 6.54%	146,773 $179,000
Q3 2021 Nov 12, 2021	BUY	$1.2 - $1.5 $165,320 - $206,650	137,767 New	137,767 $188,000

Others Institutions Holding GERN

# of Institutions

274

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Geron Corp Transaction History